Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Inhibition of HIV-1 protease: the rigidity perspective

Tools
- Tools
+ Tools

Heal, J. W., Jiménez Roldán, J. E. (José Emilio), Wells, Stephen A., Freedman, R. B. and Roemer, Rudolf A.. (2012) Inhibition of HIV-1 protease: the rigidity perspective. Bioinformatics, Vol.28 (No.3). pp. 350-357. ISSN 1367-4803

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1093/bioinformatics/btr683

Abstract

Motivation: HIV-1 protease is a key drug target due to its role in the life cycle of the HIV-1 virus. Rigidity analysis using the software First is a computationally inexpensive method for inferring functional information from protein crystal structures. We evaluate the rigidity of 206 high-resolution (2 angstrom or better) X-ray crystal structures of HIV-1 protease and compare the effects of different inhibitors binding to the enzyme. Results: Inhibitor binding has little effect on the overall rigidity of the protein homodimer, including the rigidity of the active site. The principal effect of inhibitor binding on rigidity is to constrain the flexibility of the beta-hairpin flaps, which move to allow access to the active site of the enzyme. We show that commercially available antiviral drugs which target HIV-1 protease can be divided into two classes, those which significantly affect flap rigidity and those which do not. The non-peptidic inhibitor tipranavir is distinctive in its consistently strong effect on flap rigidity.

Item Type: Journal Article
Subjects: Q Science > Q Science (General)
Divisions: Faculty of Science > Computer Science
Faculty of Science > Life Sciences (2010- )
Faculty of Science > Molecular Organisation and Assembly in Cells (MOAC)
Faculty of Science > Physics
Journal or Publication Title: Bioinformatics
Publisher: Oxford University Press
ISSN: 1367-4803
Date: 2012
Volume: Vol.28
Number: No.3
Number of Pages: 8
Page Range: pp. 350-357
Identification Number: 10.1093/bioinformatics/btr683
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: EPSRC , Leverhulme Trust (LT)
Grant number: MOAC DTC EP/F500378/1 (EPSRC)
URI: http://wrap.warwick.ac.uk/id/eprint/42688

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us